Endocrinology, Vol 136, 4776-4781, Copyright © 1995 by Endocrine Society

ARTICLES

Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells

AM Delany and E Canalis
Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105, USA.

Insulin-like growth factor I (IGF-I) is an abundant autocrine and paracrine growth factor secreted by osteoblasts. It promotes osteoblast proliferation and expression of their differentiated phenotype. Glucocorticoids decrease IGF-I production by osteoblasts, which may mediate some actions of the steroid on bone in both normal and pathological states. The mechanisms by which the glucocorticoid cortisol down-regulates IGF-I transcripts were explored using cultures of osteoblast-enriched cells derived from fetal rat calvaria (Ob cells). Repression of IGF-I transcripts was apparent after 8 h of treatment, was sustained for at least 24 h, and was not altered by cotreatment with cycloheximide. Cortisol did not alter the stability of IGF-I messenger RNAs in transcriptionally arrested Ob cells. Cortisol decreased IGF-I heterogeneous nuclear RNA and gene transcription, as determined by reverse transcription-linked polymerase chain reaction and nuclear run-on assay, respectively. Transient transfection of Ob cells with constructs containing portions of the rat IGF-I exon 1 promoter and 5'-flanking DNA linked to the reporter gene luciferase were performed to determine glucocorticoid-responsive region of the rat IGF-I exon 1 promoter was localized to 34 to 192 relative to the first start site of transcription. In conclusion, cortisol inhibits the transcription of IGF-I in osteoblasts, an effect that may be relevant to the actions of cortisol in bone.

This article has been cited by other articles:

				W. M. Naranjo, S. Yakar, M. Sanchez-Gomez, A. U. Perez, J. Setser, and D. LERoith Protein Calorie Restriction Affects Nonhepatic IGF-I Production and the Lymphoid System: Studies Using the Liver-Specific IGF-I Gene-Deleted Mouse Model Endocrinology, June 1, 2002; 143(6): 2233 - 2241. [Abstract] [Full Text] [PDF]

				E. Canalis and A. Giustina Glucocorticoid-Induced Osteoporosis: Summary of a Workshop J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5681 - 5685. [Full Text] [PDF]

				A. M. Delany, D. Durant, and E. Canalis Glucocorticoid Suppression of IGF I Transcription in Osteoblasts Mol. Endocrinol., October 1, 2001; 15(10): 1781 - 1789. [Abstract] [Full Text] [PDF]

				R. C. Pereira, D. Durant, and E. Canalis Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E570 - E576. [Abstract] [Full Text] [PDF]

				F. Blanquaert, R. C. Pereira, and E. Canalis Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E509 - E515. [Abstract] [Full Text] [PDF]

				T. L. McCarthy, C. Ji, Y. Chen, K. Kim, and M. Centrella Time- and Dose-Related Interactions between Glucocorticoid and Cyclic Adenosine 3',5'-Monophosphate on CCAAT/Enhancer-Binding Protein-Dependent Insulin-Like Growth Factor I Expression by Osteoblasts Endocrinology, January 1, 2000; 141(1): 127 - 137. [Abstract] [Full Text] [PDF]

				E. Dennison, P. Hindmarsh, C. Fall, S. Kellingray, D. Barker, D. Phillips, and C. Cooper Profiles of Endogenous Circulating Cortisol and Bone Mineral Density in Healthy Elderly Men J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3058 - 3063. [Abstract] [Full Text]

				K. Mori, A. Shioi, S. Jono, Y. Nishizawa, and H. Morii Dexamethasone Enhances In Vitro Vascular Calcification by Promoting Osteoblastic Differentiation of Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2112 - 2118. [Abstract] [Full Text] [PDF]

				C. H. Lang, G. J. Nystrom, and R. A. Frost Regulation of IGF binding protein-1 in Hep G2 cells by cytokines and reactive oxygen species Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G719 - G727. [Abstract] [Full Text] [PDF]

				R. C. Pereira, F. Blanquaert, and E. Canalis Cortisol Enhances the Expression of mac25/Insulin-Like Growth Factor-Binding Protein-Related Protein-1 in Cultured Osteoblasts Endocrinology, January 1, 1999; 140(1): 228 - 232. [Abstract] [Full Text]

				E. Canalis Editorial: Inhibitory Actions of Glucocorticoids on Skeletal Growth. Is Local Insulin-Like Growth Factor I to Blame? Endocrinology, July 1, 1998; 139(7): 3041 - 3042. [Full Text] [PDF]

				V. Gangji, S. Rydziel, B. Gabbitas, and E. Canalis Insulin-Like Growth Factor II Promoter Expression in Cultured Rodent Osteoblasts and Adult Rat Bone Endocrinology, May 1, 1998; 139(5): 2287 - 2292. [Abstract] [Full Text] [PDF]

				M. Milne, M.-I. Kang, J. M. Quail, and D. T. Baran Thyroid Hormone Excess Increases Insulin-Like Growth Factor I Transcripts in Bone Marrow Cell Cultures: Divergent Effects on Vertebral and Femoral Cell Cultures Endocrinology, May 1, 1998; 139(5): 2527 - 2534. [Abstract] [Full Text] [PDF]

				J. Rubin, D. M. Biskobing, L. Jadhav, D. Fan, M. S. Nanes, S. Perkins, and X. Fan Dexamethasone Promotes Expression of Membrane-Bound Macrophage Colony-Stimulating Factor in Murine Osteoblast-Like Cells Endocrinology, March 1, 1998; 139(3): 1006 - 1012. [Abstract] [Full Text] [PDF]

				C. Ohlsson, B.-A. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg Growth Hormone and Bone Endocr. Rev., February 1, 1998; 19(1): 55 - 79. [Abstract] [Full Text]

				N. Franchimont, V. Gangji, D. Durant, and E. Canalis Interleukin-6 with Its Soluble Receptor Enhances the Expression of Insulin-Like Growth Factor-I in Osteoblasts Endocrinology, December 1, 1997; 138(12): 5248 - 5255. [Abstract] [Full Text] [PDF]

				X. Wang, Y. Yang, and M. L. Adamo Characterization of the Rat Insulin-Like Growth Factor I Gene Promoters and Identification of a Minimal Exon 2 Promoter Endocrinology, April 1, 1997; 138(4): 1528 - 1536. [Abstract] [Full Text] [PDF]

				T. Bui, C. Kuo, P. Rotwein, and D. S. Straus Prostaglandin A2 Specifically Represses Insulin-Like Growth Factor-I Gene Expression in C6 Rat Glioma Cells Endocrinology, March 1, 1997; 138(3): 985 - 993. [Abstract] [Full Text] [PDF]

				A. P.J. King, M.-J. Tseng, C. D. Logsdon, N. Billestrup, and C. Carter-Su Distinct Cytoplasmic Domains of the Growth Hormone Receptor Are Required for Glucocorticoid- and Phorbol Ester-induced Decreases in Growth Hormone (GH) Binding. THESE DOMAINS ARE DIFFERENT FROM THAT REPORTED FOR GH-INDUCED RECEPTOR INTERNALIZATION J. Biol. Chem., July 26, 1996; 271(30): 18088 - 18094. [Abstract] [Full Text] [PDF]

				E. Smith, R. A. Redman, C. R. Logg, G. A. Coetzee, N. Kasahara, and B. Frenkel Glucocorticoids Inhibit Developmental Stage-specific Osteoblast Cell Cycle. DISSOCIATION OF CYCLIN A-CYCLIN-DEPENDENT KINASE 2 FROM E2F4-p130 COMPLEXES J. Biol. Chem., June 23, 2000; 275(26): 19992 - 20001. [Abstract] [Full Text] [PDF]

				S. K. Winchester, N. Selvamurugan, R. C. D'Alonzo, and N. C. Partridge Developmental Regulation of Collagenase-3 mRNA in Normal, Differentiating Osteoblasts through the Activator Protein-1 and the runt Domain Binding Sites J. Biol. Chem., July 21, 2000; 275(30): 23310 - 23318. [Abstract] [Full Text] [PDF]